scorecardresearch
Monday, September 22, 2025
TopicVaccine authorisation

Topic: Vaccine authorisation

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

On Camera

Festive seasons align with the rollout of GST 2.0. Citizens to get more money in hand

The new norm marks a decisive shift from the earlier complex system that created friction for households and small businesses alike.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

30 civilians killed as Pakistan Air Force strikes Khyber Pakhtunkhwa village with China-made bombs

While Pakistani authorities have not clarified what intended target was, the incident adds to a troubling pattern of PAF strikes killing civilians, including women and children.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.